Nalaganje...
cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?
Shranjeno v:
| izdano v: | EBioMedicine |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7341337/ https://ncbi.nlm.nih.gov/pubmed/32650267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102886 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|